{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:41:33Z","timestamp":1770723693235,"version":"3.49.0"},"reference-count":0,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,6]]},"abstract":"<jats:p>By pairing a BCMA-targeted T-cell engager with an anti-CD38 antibody, researchers achieved strikingly deep remissions and sharply reduced relapse risk in patients with relapsed myeloma. The results suggest this dual immune-directed strategy could challenge current treatment sequencing, including when to deploy engineered T-cell therapies.<\/jats:p>","DOI":"10.1158\/2159-8290.cd-nw2025-0114","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T15:32:47Z","timestamp":1766417567000},"page":"OF1-OF1","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two Drugs, One Stunning Myeloma Result"],"prefix":"10.1158","volume":"16","member":"1086","published-online":{"date-parts":[[2025,12,19]]},"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/doi\/10.1158\/2159-8290.CD-NW2025-0114\/771179\/Two-Drugs-One-Stunning-Myeloma-ResultTwo-Drugs-One","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/2\/OF1\/772096\/Two-Drugs-One-Stunning-Myeloma-ResultTwo-Drugs-One","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/2\/OF1\/772096\/Two-Drugs-One-Stunning-Myeloma-ResultTwo-Drugs-One","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:33:52Z","timestamp":1770651232000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/2\/OF1\/772096\/Two-Drugs-One-Stunning-Myeloma-ResultTwo-Drugs-One"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12,19]]},"published-print":{"date-parts":[[2026,2,6]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-nw2025-0114","relation":{},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]}}}